AllerGene AI Therapeutics Appoints Biotech Industry Veteran Gad Berdugo to Board of Directors

Explorium Capital invested in the company through the Cane Angel Network, further strengthening AllerGene's strategic growth initiatives. MIAMI, June 9, 2026 /PRNewswire/ -- AllerGene AI Therapeutics, a biotechnology company developing first-in-class in vivo targeted-lipid nanoparticle...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.